Recent Finacing
Recent Raise
Provenance Biopharmaceuticals is a Waltham, MA clinical-stage biotech developing the immunocytokine DI-Leu16-IL2 for non-Hodgkin’s lymphoma and other hematologic cancers, conducting an investigator-sponsored Phase I trial.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor